1 / 17

Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator

Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator. Dr Siobhan Jennings, Consultant in Public Health Medicine National Coordinator Irish Cardiac Society. Source : WHO-HFA-DB. Bennett K et al J Epi Community Health 2006. CHD TRENDS: US ( x age groups)

burt
Download Presentation

Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator Dr Siobhan Jennings, Consultant in Public Health Medicine National Coordinator Irish Cardiac Society

  2. Source: WHO-HFA-DB

  3. Bennett K et al J Epi Community Health 2006

  4. CHD TRENDS: US ( x age groups) Trends in Age-Specific Mortality Rates From Coronary Heart Disease Ford, E. S. et al. J Am Coll Cardiol 2007;50:2128-2132

  5. SLÁN 2007 Hypertension Profile, n=1,207 age 45+

  6. CVD Medication Use - GMS Scheme (1998-2006)

  7. CVD Prevention • Population approach • Secondary prevention • High risk approach • 4JTF from ESC adopted by CVD Policy, 2010 • Record risk factors, Assess risk, consider intervention

  8. ESC brief for National Co-ordinator • Facilitate……….. endorsement, adaptation, and publication of guidelines • Co-ordinate ……….adaptation and dissemination of CVD Preventions tools • Build national alliances(multidisciplinary, professional) • Make contact with Health(and Local) Authorities promoting EHHC • Act asdirect contact personwith ESC Co-ordinator

  9. National Coordinator – my approach • Asked by Irish Cardiac Society • Discussions with IHF (and within HSE) • Review of Councils - Council on Prevention • Resource - Project manager (B. Caffrey – Armstrong) • Multidisciplinary Consensus Conference (today) • Meeting with Dr Joe Clarke, HSE Primary Care Clinical programme

  10. IHF Council on Prevention of CVDMembership • Prof Ian Graham (Chair) • Dr Siobhan Jennings (National Coordinator, ROI) • Dr Mahan Varma (National Coordinator, NI) • Prof H Mc Gee • Dr Joseph Harbison • Dr Angie Brown • Dr John Cox • Dr Pat Doorley • Prof Eoin O Brien • Dr John Devlin • Mr Michael O Shea • Ms Bridget Caffrey- Armstrong (Project Manager)

  11. National Coordinator – my approach • Asked by Irish Cardiac Society • Discussions with IHF (and within HSE) • Review of Councils - Council on Prevention • Resource - Project manager (B. Caffrey – Armstrong) • Multidisciplinary Consensus Conference (today) • Meeting with Dr Joe Clarke, HSE Primary Care Clinical programme

  12. National Coordinator – my approach • Baseline survey in GP with ICGP planned • Relationship with • Clinical programmes in HSE (HF, ACS, Stroke and Primary Care) • Health Promotion in HSE • DOH&C • National Clinical Effectiveness Committee to mandate national guidelines • Organisations who have taken action - CROI MyAction programme

  13. Croi MyActionA nurse led, multidisciplinary CVD prevention programmeAn initiative by Croi in collaboration with HSE West PCCC and Imperial College London • Based on the ESC 4JTF and SCORE • Modelled on EuroAction study (Lancet 2008) • 12-16 week intensive lifestyle programme with baseline, end of programme and 1 year follow-up • Co-ordinated by 2 Nurses, Dietitian, Physiotherapist and Medical sessional support • Family based – enrol patient and partner

  14. OutcomesBased on first 120 patients

  15. Summary • Ireland -a significant decline in mortality from CVD but • We’re not there yet • We have challenges ahead • Systematic approach needed to preventing CVD in those at high risk • ESC 4JTF guidelines • SCORE as validated tool appropriate to European population

  16. Philosophy - REDUCING THE INCIDENCE OF CVD: The European Heart Health Charter“Every child born in the new millenium has the rightto live until the age of at least 65 without suffering from avoidable cardiovascular disease” (June 2007)

More Related